Market Place
Sourcing Support
U.S. subpoenas Endo for information on opioid painkillers
11 Jan 2018 //
REUTERS
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Endo International plc
23 Jun 2017 //
PR NEWSWIRE
US FDA requests Endo Pharma remove Opana ER for risks related to abuse
12 Jun 2017 //
BIOSPECTRUM
FDA Asks Endo Pharma to Stop Selling Opana ER Amid Opioid Crisis
10 Jun 2017 //
BIOSPACE
Endo Statement On FDA Advisory Committees` Vote Related To OPANA® ER
14 Mar 2017 //
PR NEWSWIRE
FDA Panel To Re-Examine Opana ER
11 Mar 2017 //
SEEKING ALPHA
Endo Announces Agreement to Resolve FTC Investigation and Litigation
23 Jan 2017 //
PR NEWSWIRE
Grunenthal says anti-crush tech Endo uses for Opana ER helps prevent abuse
25 Aug 2016 //
IN PHARMATECHNOLOGIST
Endo withdraws abuse-deterrent labelling for Opana ER
15 Aug 2016 //
PHARMATIMES
Cash is not king: FTC sues drug maker over pay-to-delay deal
01 Apr 2016 //
STAT
Depomed Acquires U.S. Rights, First-in-Class Pain Product from Grunenthal
17 Nov 2015 //
PR NEWSWIRE
Abandoned Painkiller Makes a Comeback
10 May 2015 //
MEDPAGE TODAY
Sun`s Generic Oxymorphone Hcl Approved in USA For Moderate to Severe Pain
30 Apr 2015 //
FDA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.